These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 20007525

  • 1. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy.
    Eilers RE, Gandhi M, Patel JD, Mulcahy MF, Agulnik M, Hensing T, Lacouture ME.
    J Natl Cancer Inst; 2010 Jan 06; 102(1):47-53. PubMed ID: 20007525
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors.
    Osio A, Mateus C, Soria JC, Massard C, Malka D, Boige V, Besse B, Robert C.
    Br J Dermatol; 2009 Sep 06; 161(3):515-21. PubMed ID: 19466958
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
    Tejwani A, Wu S, Jia Y, Agulnik M, Millender L, Lacouture ME.
    Cancer; 2009 Mar 15; 115(6):1286-99. PubMed ID: 19170238
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors.
    Tan EH, Chan A.
    Ann Pharmacother; 2009 Oct 15; 43(10):1658-66. PubMed ID: 19755624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.
    Lynch TJ, Kim ES, Eaby B, Garey J, West DP, Lacouture ME.
    Oncologist; 2007 May 15; 12(5):610-21. PubMed ID: 17522250
    [Abstract] [Full Text] [Related]

  • 10. Skin infections in 401 renal transplant recipients in southern Turkey.
    Dicle O, Parmaksizoglu B, Gurkan A, Tuncer M, Demirbas A, Yilmaz E.
    Exp Clin Transplant; 2009 Jun 15; 7(2):133-6. PubMed ID: 19715520
    [Abstract] [Full Text] [Related]

  • 11. [Cutaneous infections related to permanent tattooing].
    Kluger N.
    Med Mal Infect; 2011 Mar 15; 41(3):115-22. PubMed ID: 21144685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office.
    Bruce AM, Spencer JM.
    J Drugs Dermatol; 2008 Aug 15; 7(8):751-5. PubMed ID: 18720691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC.
    Clin Ther; 2009 Sep 15; 31(9):1936-45. PubMed ID: 19843483
    [Abstract] [Full Text] [Related]

  • 18. High association of human herpesvirus 8 in large-plaque parapsoriasis and mycosis fungoides.
    Kreuter A, Bischoff S, Skrygan M, Wieland U, Brockmeyer NH, Stücker M, Altmeyer P, Gambichler T.
    Arch Dermatol; 2008 Aug 15; 144(8):1011-6. PubMed ID: 18711073
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous reactions related to systemic immunomodulators and targeted therapeutics.
    Hammond-Thelin LA.
    Dermatol Clin; 2008 Jan 15; 26(1):121-59, ix. PubMed ID: 18023775
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.